ISIS 443139 10 mg
ISIS 443139-CS1
Phase 2 small_molecule completed
Quick answer
ISIS 443139 10 mg for Huntington's Disease is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Huntington's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed